Table 2.
Extension study; Demographics of selected subjects from the AIBL cohort
| N | Gender (M/F) |
Mean age* |
CTL | SMC | MCI | AD | APOE ε4 (carrier/non-carrier) |
Mean MMSE |
|
|---|---|---|---|---|---|---|---|---|---|
| Low neocortical SUVR (PiB−) | 38 | 20/18 | 75.8 ± 6.53 | 13 | 18 | 7 | 0 | 14/24 | 28.3 |
| High neocortical SUVR (PiB+) | 40 | 20/20 | 80.9 ± 8.22 | 6 | 13 | 15 | 6 | 25/15 | 26.8 |
| Total | 78 | 40/38 | 78.35 | 19 | 31 | 22 | 6 | 39/39 | 27.55 |
AD, Alzheimer’s disease; APOE, Apolipoprotein E; CTL, control subject; M/F, male/female; MCI, mild cognitive impairment; MMSE, Mini-Mental State Examination; PiB, Pittsburgh compound B; SUVR, standardized uptake value ratio; SMC, subjective memory complaint.
*
Data presented as mean ± standard deviation.